Literature DB >> 24746689

Microbial view of central nervous system autoimmunity.

Kerstin Berer1, Gurumoorthy Krishnamoorthy2.   

Abstract

Not much is known about the initial events leading to the development of the central nervous system (CNS)-specific autoimmune disorder Multiple Sclerosis (MS). Environmental factors are suspected to trigger the pathogenic events in people with genetic disease susceptibility. Historically, many infectious microbes were linked to MS, but no infection has ever been demonstrated to be the cause of the disease. Recent emerging evidence from animal models of MS suggests a causal link with resident commensal bacteria. Microbial organisms may trigger the activation of CNS-specific, auto-aggressive lymphocytes either through molecular mimicry or via bystander activation. In addition, several gut microbial metabolites and bacterial products may interact with the immune system to modulate CNS autoimmunity.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Central nervous system; Gut microbiota; Multiple sclerosis

Mesh:

Year:  2014        PMID: 24746689     DOI: 10.1016/j.febslet.2014.04.007

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  47 in total

1.  Evaluation of an Expanded Disability Status Scale (EDSS) modeling strategy in multiple sclerosis.

Authors:  Hua Cao; Laurent Peyrodie; Olivier Agnani; Fabrice Cavillon; Patrick Hautecoeur; Cécile Donzé
Journal:  Med Biol Eng Comput       Date:  2015-09-07       Impact factor: 2.602

2.  One more role for the gut: microbiota and blood brain barrier.

Authors:  Laure Michel; Alexandre Prat
Journal:  Ann Transl Med       Date:  2016-01

Review 3.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

4.  Interactions of antisera to different Chlamydia and Chlamydophila species with the ribosomal protein RPS27a correlate with impaired protein synthesis in a human choroid plexus papilloma cell line.

Authors:  Abdullah Almamy; Christian Schwerk; Horst Schroten; Hiroshi Ishikawa; Abdul Rahman Asif; Bernhard Reuss
Journal:  Immunol Res       Date:  2017-12       Impact factor: 2.829

Review 5.  T cell responses in the central nervous system.

Authors:  Thomas Korn; Axel Kallies
Journal:  Nat Rev Immunol       Date:  2017-01-31       Impact factor: 53.106

Review 6.  Multiple Sclerosis and T Lymphocytes: An Entangled Story.

Authors:  Laurine Legroux; Nathalie Arbour
Journal:  J Neuroimmune Pharmacol       Date:  2015-05-07       Impact factor: 4.147

7.  Gut microbiota in early pediatric multiple sclerosis: a case-control study.

Authors:  Helen Tremlett; Douglas W Fadrosh; Ali A Faruqi; Feng Zhu; Janace Hart; Shelly Roalstad; Jennifer Graves; Susan Lynch; Emmanuelle Waubant
Journal:  Eur J Neurol       Date:  2016-05-13       Impact factor: 6.089

Review 8.  Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.

Authors:  Lei Yang; Dewei Tan; Hua Piao
Journal:  Neurochem Res       Date:  2016-04-21       Impact factor: 3.996

9.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

Authors:  Kerstin Berer; Lisa Ann Gerdes; Egle Cekanaviciute; Xiaoming Jia; Liang Xiao; Zhongkui Xia; Chuan Liu; Luisa Klotz; Uta Stauffer; Sergio E Baranzini; Tania Kümpfel; Reinhard Hohlfeld; Gurumoorthy Krishnamoorthy; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

Review 10.  The Gut-CNS Axis in Multiple Sclerosis.

Authors:  Atsushi Kadowaki; Francisco J Quintana
Journal:  Trends Neurosci       Date:  2020-07-07       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.